• Development of bimanual performance in young children with cerebral palsy 

      Klevberg, Gunvor Lilleholt; Elvrum, Ann-Kristin; Zucknick, Manuela; Elkjær, Sonja; Østensjø, Sigrid; Krumlinde-Sundholm, Lena; Kjeken, Ingvild; Jahnsen, Reidun Birgitta (Journal article; Peer reviewed, 2018)
      Aim To describe the development of bimanual performance among young children with unilateral or bilateral cerebral palsy (CP). Method A population‐based sample of 102 children (53 males, 49 females), median age 28.5 ...
    • Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study 

      Schellhorn, Till; Zucknick, Manuela; Askim, Torunn; Munthe-Kaas, Ragnhild; Ihle-Hansen, Hege; Seljeseth, Yngve Müller; Knapskog, Anne Brita; Næss, Halvor; Ellekjær, Hanne; Thingstad, Pernille; Wyller, Torgeir Bruun; Saltvedt, Ingvild; Beyer, Mona Kristiansen (Peer reviewed; Journal article, 2021)
      Background Chronic brain pathology and pre-stroke cognitive impairment (PCI) is predictive of post-stroke dementia. The aim of the current study was to measure pre-stroke neurodegenerative and vascular disease burden ...
    • Real-life use of niraparib in a patient access program in Norway 

      Vilming, Bente; Dahl, Jørgen Fallås; Aune, Guro; Zucknick, Manuela; Lindemann, Kristina (Master thesis, 2021)
      Hensikt: PARP(polyadenosin difosfat [ADP]–ribose polymerase)-hemmere har dukket opp som en ny standard i vedlikeholdsbehandling av eggstokkreft, og viser seg å være effektivt i nydiagnostisert sykdom og i residivsammenheng ...
    • Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer 

      Elgaaen, Bente Vilming; Dahl, Jørgen Fallås; Bentzen, Anne Gry; Ingebrigtsen, Vibeke Anett; Nilsen, Elisabeth Berge; Vistad, Ingvild; Dørum, Anne; Popova, Olesya; Bjørge, Line; Zucknick, Manuela; Aune, Guro; Lindemann, Kristina Yvonne Kathe (Peer reviewed; Journal article, 2023)
      Objectives The aim of this study was to provide real-world efficacy and safety data on niraparib maintenance treatment in patients with non-germline (gBRCA)1/2 mutated platinum-sensitive recurrent ovarian cancer. Methods ...